申请人:Shanghai Dongxi Zhihui
Biological Medicine Co., Ltd.
公开号:EP3750904A1
公开(公告)日:2020-12-16
The present invention relates to a novel therapeutic drug for a neurodegenerative disease and an application thereof. Provided is a novel compound of formula (I). The compound can effectively facilitate the proliferation of neural stem cells in both in vitro and in vivo experiments and can be used as a treatment approach for facilitating neuroregeneration to fight against cognitive decline associated with aging or a neurodegenerative disease.
本发明涉及一种治疗神经退行性疾病的新型治疗药物及其应用。本发明提供了一种新型的式(I)化合物。该化合物可在体外和体内实验中有效促进神经干细胞的增殖,并可用作促进神经再生的治疗方法,以对抗与衰老或神经退行性疾病相关的认知能力下降。